Cross-Sectional Evaluation of Noninvasively Detected Skin Intrinsic Fluorescence and Mean Hemoglobin A1c in Type 1 Diabetes

1 MedStar Health Research Institute , Hyattsville, Maryland.
Diabetes Technology &amp Therapeutics (Impact Factor: 2.11). 01/2013; 15(2). DOI: 10.1089/dia.2012.0211
Source: PubMed


This study evaluated the relationship between skin intrinsic fluorescence (SIF) and long-term mean hemoglobin A1c (HbA1c) in individuals with type 1 diabetes.

Subjects and methods:
We undertook a cross-sectional analysis of 172 individuals with type 1 diabetes followed longitudinally with HbA1c data available over an average of 16.6 years. SIF was evaluated cross-sectionally using the SCOUT DS device (VeraLight Inc., Albuquerque, NM) and correlated with most recent HbA1c and long-term mean HbA1c. Potential determinants of this relationship, including age, gender, smoking status, duration of diabetes, and renal function, were also evaluated.

Age-adjusted skin intrinsic fluorescence significantly correlated with long-term mean HbA1c (R=0.44, P<0.0001). In contrast, there was no significant relationship between SIF and most recent HbA1c (R=0.14, P=0.075). The best-fit model describing the relationship between SIF and mean HbA1c controlled for factors of age, duration of disease, renal function, and site of study conduct. Controlling for these factors was also important in understanding the relationship between most recent HbA1c and SIF. Evaluating longer-term HbA1c data also strengthened the relationship between SIF and mean HbA1c. In the presence of renal dysfunction or damage, as indicated by an estimated glomerular filtration rate of <60 mL/min/1.73 m2 or presence of gross proteinuria, there was no significant correlation between SIF and mean HbA1c.

Noninvasive detection of SIF significantly correlates with long-term mean HbA1c, providing insight into long-term glycemic exposure. Age, duration of diabetes, and renal function are potential contributors to this relationship.

1 Follower
7 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Our aim was to assess the association between skin autofluorescence (AF) related to advanced glycation end products (AGEs) accumulation and long-term metabolic control, microvascular complications and carotid intima-media thickness (IMT) in an observational cohort of type 1 diabetes (DM1). The analysis included 77 patients with DM1 (28 women and 49 men) aged 38 (IQR: 34-41), diabetes duration 15 (14-17), participating in Poznan Prospective Study (PoProStu). Skin AF was measured with AGE Reader (DiagnOptics). We found 50% of any microvascular complication; 37% of retinopathy, 37% of diabetic kidney disease and 22% of distal symmetrical neuropathy. Median carotid IMT was 0.57 (0.52-0.67)mm and skin AF 2.2 (IQR: 1.9-2.6). We found positive correlation between skin AF and patients' age (r=0.31, p=0.006), mean HbA1c from the observation time (r=0.35, p=0.001) and IMT (r=0.39, p<0.001). In multivariate logistic regression presence of microvascular complications was independently associated with skin AF: for retinopathy (OR 3.49; 95%CI:1.08-11.28, p=0.03), for diabetic kidney disease (OR 3.62; 95%CI:1.16-11.28, p=0.02), for neuropathy (OR 5.01; 95%CI:1.21-20.77, p=0.02) and for any microangiopathy (OR 3.13; 95%CI: 1.06-9.18, p=0.03). Skin AF is a reliable marker of past glycaemic control of diabetes. Increased accumulation of AGEs is related to the presence of diabetic microangiopathy as well as subclinical macroangiopathy in patients with type 1. Copyright © 2015. Published by Elsevier Inc.
    Microvascular Research 01/2015; 98. DOI:10.1016/j.mvr.2015.01.002 · 2.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Advanced glycation end products are involved in the vascular complications of diabetes, in chronic kidney disease, and in the aging process. Their accumulation in the elderly people, as reflected by skin autofluorescence (sAF), may be a marker of metabolic memory. We aimed to examine the association of sAF with glycemic and renal status 10 years earlier in older persons. In retrospective cohort study, 328 elderly community dwellers aged of 75 years and over had sAF measurement 10 years after their inclusion in the Three-City cohort. Fasting plasma glucose and serum creatinine were measured at baseline and at 10-year follow-up. In 125 participants, HbA1c was available at these two times. Associations between sAF and the glycemic and renal status 10 years before were analyzed by multivariate linear regression adjusted for age, sex, hypertension, body mass index, hypertriglyceridemia, and smoking. Participants were 82.4 (standard deviation = 4.1) years on average, and their mean sAF was 2.8 (standard deviation = 0.7) arbitrary units (AU). After adjustment, sAF was higher in participants with long-standing diabetes (+0.38 AU, p = .01) or chronic kidney disease (+0.29 AU, p = .02) compared with healthy participants. sAF was related to fasting plasma glucose (+1 mmol/L associated with +0.08 AU, p = .01) and HbA1c (+1% associated with +0.15 AU, p = .03) 10 years earlier, but not to the current fasting plasma glucose (p = .82) and HbA1c (p = .32). sAF was also related to the distal and current estimated glomerular filtration rates (p = .002 and .004, respectively). sAF reflects glycemic and renal status 10 years before, supporting its value as a marker of metabolic memory in the elderly people. © The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail:
    The Journals of Gerontology Series A Biological Sciences and Medical Sciences 01/2015; 70(7). DOI:10.1093/gerona/glu243 · 5.42 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Accumulation of advanced glycation end-products (AGEs) is thought to contribute to limited joint mobility in people with diabetes mellitus (DM) but the relationships between AGES, shoulder structural changes, movement and disability are not understood. Determine the differences and relationships between the Skin Intrinsic Fluorescence (SIF), a proxy measure of AGEs, biceps and supraspinatus tendon thickness, upper extremity movement and disability in groups with and without DM. Cross-sectional, case-control study METHODS: Fifty-two subjects participated; 26 with Type 2 DM and 26 sex, age and BMI matched controls. The main outcome measures were: SIF; biceps and supraspinatus tendon thickness; three-dimensional peak shoulder motion; and Disability of the Arm, Shoulder and Hand (DASH) questionnaires. Mean SIF measures were 19% higher in the DM group compared to the control group (P<0.05). Biceps (mean and 95% confidence interval) (4.7 (4.4, 5.0) vs. 3.2 (2.9, 3.5) mm) and supraspinatus (6.4 (5.9, 6.8) vs. 4.9 (4.4, 5.3) mm) tendons were thicker, and peak humerothoracic elevation, 139 (135, 146)° vs. 150 (146, 155)° and glenohumeral external rotation, 35 (26, 46)° vs. 51 (41, 58)° were reduced in the DM group compared to the control group (P<0.05). In the DM group, the SIF was correlated to biceps tendon thickness, DASH score, and shoulder motion (r = 0.44-0.51, P<0.05). The SIF score and shoulder strength explained 64% of the DASH scores (P<0.01). Since this was a cross-sectional study design, we were not able to establish a cause-effect relationship. Accumulation of AGEs in the connective tissues of individuals with DM appears to be associated with increased tendon thickness, and decreased shoulder joint mobility and upper extremity function. Physical therapists should be aware of these possible metabolic effects on structure, movement, and disability when treating people with diabetes. © 2015 American Physical Therapy Association.
    Physical Therapy 04/2015; 95(8). DOI:10.2522/ptj.20140340 · 2.53 Impact Factor